Carlos Gallardo is the founder and CEO of CG Health Ventures. See contact routes.
Carlos Gallardo is the founder and CEO of CG Health Ventures, a Barcelona-based venture capital firm he established in 2014 after spending 12 years in the pharmaceutical industry at Almirall and Pfizer. He holds an MS in Industrial Engineering from the UPC and an MBA from Stanford University, and currently serves as Chairman and CEO of Almirall. His firm invests in early-stage healthcare companies, specifically Seed and Series A rounds, focusing on health IT, digital health, and genomics across Europe and the US. CG Health Ventures targets startups with existing market traction and the potential for global scalability, providing capital alongside sector expertise and operational support. Notable portfolio companies include the German biotech S-Biomedic, the US digital health firm Virta Health, and the Spanish company Skingdom. While the firm has executed at least seven investments since its founding, specific typical check sizes and whether Gallardo acts as a lead or follow investor are not publicly detailed in available sources. Gallardo is also an Investment Advisor at Nina Capital and previously served as a Venture Partner at Ysios Capital
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Barcelona when building a target list.
Investors like Carlos Gallardo · Full investor directory · Investor access · Company funding database